Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2021

Open Access 01-12-2021 | Arthritis | Research article

Anti-inflammatory effect of different curcumin preparations on adjuvant-induced arthritis in rats

Authors: Ieva Rinkunaite, Egidijus Simoliunas, Milda Alksne, Dominyka Dapkute, Virginija Bukelskiene

Published in: BMC Complementary Medicine and Therapies | Issue 1/2021

Login to get access

Abstract

Background

Curcumin, a natural polyphenolic substance, has been known for more than two millennia as having strong anti-inflammatory activity towards multiple ailments, including arthritis. The main drawback of curcumin is its poor solubility in water, which leads to low intestinal absorption and minimal bioavailability. In this study, we aimed to compare the anti-arthritic in vivo effect of different curcumin preparations – basic curcumin extract, micellar curcumin, curcumin mixture with piperine, and microencapsulated curcumin.

Methods

Arthritis was induced in Wistar rats by complete Freund’s adjuvant, and the severity of arthritis was evaluated daily using the arthritis score system. Curcumin preparations were given to animals per os daily for 20 consecutive days, starting at 6th day after arthritis induction. To determine the inflammatory background, pro-inflammatory cytokines were determined using the ELISA test. In addition, hematologic test, weight change, and limb swelling were tracked.

Results

Our results indicate that curcumin had a rather weak effect on arthritis progression in the Wistar rat model, microencapsulated curcumin effectively prevented the progression of arthritis – the disease stabilized after 10 days of supplementation. It also reduced the levels of immune cells (neutrophils and leukocytes), as well as pro-inflammatory cytokines – TNFα, IL-1, and IL-6, which levels were close to arthritis-free control. Other formulations of curcumin had lower or no effect on arthritis progression.

Conclusion

Our study shows that the same concentrations of curcumin had a distinctly expressed positive anti-inflammatory effect depending on the form of its delivery. Specifically, we found that microencapsulated curcumin had the most promising effect for treatment.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MHW. Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis. Cochrane Database Syst. 2014;Rev:CD010208. Hoving JL, Lacaille D, Urquhart DM, Hannu TJ, Sluiter JK, Frings-Dresen MHW. Non-pharmacological interventions for preventing job loss in workers with inflammatory arthritis. Cochrane Database Syst. 2014;Rev:CD010208.
2.
go back to reference Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24:121–32.PubMedCrossRef Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs (NSAIDs, aspirin and coxibs) on upper gastrointestinal tract. Best Pract Res Clin Gastroenterol. 2010;24:121–32.PubMedCrossRef
3.
go back to reference Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1–75.PubMedCrossRef Aggarwal BB, Sundaram C, Malani N, Ichikawa H. Curcumin: the Indian solid gold. Adv Exp Med Biol. 2007;595:1–75.PubMedCrossRef
4.
go back to reference Dai Q, Zhou D, Xu L, Song X. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug Des Devel Ther. 2018;12:4095–105.PubMedPubMedCentralCrossRef Dai Q, Zhou D, Xu L, Song X. Curcumin alleviates rheumatoid arthritis-induced inflammation and synovial hyperplasia by targeting mTOR pathway in rats. Drug Des Devel Ther. 2018;12:4095–105.PubMedPubMedCentralCrossRef
5.
go back to reference Daily JW, Yang M, Park S. Efficacy of turmeric extracts and Curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19:717–29.PubMedPubMedCentralCrossRef Daily JW, Yang M, Park S. Efficacy of turmeric extracts and Curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016;19:717–29.PubMedPubMedCentralCrossRef
6.
go back to reference Dou Y, Luo J, Wu X, Wei Z, Tong B, Yu J, Wang T, Zhang X, Yang Y, Yuan X, Zhao P, Xia Y, Hu H, Dai Y. Curcumin attenuates collagen-induced inflammatory response through the “gut-brain axis.”. J Neuroinflammation. 2018;15:6–6.PubMedPubMedCentralCrossRef Dou Y, Luo J, Wu X, Wei Z, Tong B, Yu J, Wang T, Zhang X, Yang Y, Yuan X, Zhao P, Xia Y, Hu H, Dai Y. Curcumin attenuates collagen-induced inflammatory response through the “gut-brain axis.”. J Neuroinflammation. 2018;15:6–6.PubMedPubMedCentralCrossRef
7.
go back to reference Zhang Z, Leong DJ, Xu L, He Z, Wang A, Navati M, Kim SJ, Hirsh DM, Hardin JA, Cobelli NJ, Friedman JM, Sun HB. Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res Ther. 2016;18. Zhang Z, Leong DJ, Xu L, He Z, Wang A, Navati M, Kim SJ, Hirsh DM, Hardin JA, Cobelli NJ, Friedman JM, Sun HB. Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res Ther. 2016;18.
8.
go back to reference Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest. 2004;114:582–8.PubMedPubMedCentralCrossRef Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K, Azuma Y, Kanai C, Moriizumi E, Nomura T, Nakamura T, Sakaguchi S. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest. 2004;114:582–8.PubMedPubMedCentralCrossRef
9.
go back to reference Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169:1672–92.PubMedPubMedCentralCrossRef Aggarwal BB, Gupta SC, Sung B. Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers. Br J Pharmacol. 2013;169:1672–92.PubMedPubMedCentralCrossRef
10.
go back to reference Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765–73.PubMedCrossRef Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB. Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007;28:1765–73.PubMedCrossRef
11.
go back to reference Wahlström B, Blennow G. A study on the fate of Curcumin in the rat. Acta Pharmacol Toxicol. 2009;43(2):86–92.CrossRef Wahlström B, Blennow G. A study on the fate of Curcumin in the rat. Acta Pharmacol Toxicol. 2009;43(2):86–92.CrossRef
12.
go back to reference Esatbeyoglu T, Huebbe P, Ernst IMA, Chin D, Wagner AE, Rimbach G. Curcumin—From Molecule to Biological Function. Angew Chem Int Ed. 2012;51:5308–32.CrossRef Esatbeyoglu T, Huebbe P, Ernst IMA, Chin D, Wagner AE, Rimbach G. Curcumin—From Molecule to Biological Function. Angew Chem Int Ed. 2012;51:5308–32.CrossRef
13.
go back to reference Priyadarsini KI. Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C: Photochem Rev. 2009;10(2):81–95.CrossRef Priyadarsini KI. Photophysics, photochemistry and photobiology of curcumin: studies from organic solutions, bio-mimetics and living cells. J Photochem Photobiol C: Photochem Rev. 2009;10(2):81–95.CrossRef
14.
go back to reference Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.PubMedPubMedCentralCrossRef Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.PubMedPubMedCentralCrossRef
15.
go back to reference Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–6.PubMedCrossRef Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–6.PubMedCrossRef
16.
go back to reference Bhat BG, Chandrasekhara N. Effect of black pepper and piperine on bile secretion and composition in rats. Nahrung. 1987;31:913–6.CrossRef Bhat BG, Chandrasekhara N. Effect of black pepper and piperine on bile secretion and composition in rats. Nahrung. 1987;31:913–6.CrossRef
17.
go back to reference Zayed A, Babaresh WM, Darweesh RS, El-Elimat T, Hawamdeh SS. Piperine alters the pharmacokinetics and anticoagulation of warfarin in rats. J Exp Pharmacol. 2020;12:169–79.PubMedPubMedCentralCrossRef Zayed A, Babaresh WM, Darweesh RS, El-Elimat T, Hawamdeh SS. Piperine alters the pharmacokinetics and anticoagulation of warfarin in rats. J Exp Pharmacol. 2020;12:169–79.PubMedPubMedCentralCrossRef
18.
go back to reference Song XY, Xu S, Hu JF, Tang J, Chu SF, Liu H, Han N, Li JW, Zhang DM, Li YT, Chen NH. Piperine prevents cholesterol gallstones formation in mice. Eur J Pharmacol. 2015;751:112–7.PubMedCrossRef Song XY, Xu S, Hu JF, Tang J, Chu SF, Liu H, Han N, Li JW, Zhang DM, Li YT, Chen NH. Piperine prevents cholesterol gallstones formation in mice. Eur J Pharmacol. 2015;751:112–7.PubMedCrossRef
19.
go back to reference Cui T, Wang Q, Tian X, Zhang K, Peng Y, Zheng J. Piperine is a Mechanism-based inactivator of CYP3A. Drug Metabolism and Disposition. 2019;dmd.119:088955. Cui T, Wang Q, Tian X, Zhang K, Peng Y, Zheng J. Piperine is a Mechanism-based inactivator of CYP3A. Drug Metabolism and Disposition. 2019;dmd.119:088955.
20.
go back to reference Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302(2):645–50.PubMedCrossRef Bhardwaj RK, Glaeser H, Becquemont L, Klotz U, Gupta SK, Fromm MF. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther. 2002;302(2):645–50.PubMedCrossRef
21.
go back to reference Lee SH, Kim HY, Back SY, Han HK. Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives. J Expert Opin Drug Metabolism & Toxicology. 2017;14(1):43–57.CrossRef Lee SH, Kim HY, Back SY, Han HK. Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives. J Expert Opin Drug Metabolism & Toxicology. 2017;14(1):43–57.CrossRef
22.
go back to reference Kunnumakkara AB, Harsha C, Banik K, Vikkurthi R, Sailo BL, Bordoloi D, Gupta SC, Aggarwal BB. Is curcumin bioavailability a problem in humans: lessons from clinical trials. Expert Opin Drug Metab Toxicol. 2019;15:705–33.PubMedCrossRef Kunnumakkara AB, Harsha C, Banik K, Vikkurthi R, Sailo BL, Bordoloi D, Gupta SC, Aggarwal BB. Is curcumin bioavailability a problem in humans: lessons from clinical trials. Expert Opin Drug Metab Toxicol. 2019;15:705–33.PubMedCrossRef
23.
go back to reference Purpura M, Lowery RP, Wilson JM, Mannan H, Münch G, Razmovski-Naumovski V. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur J Nutr. 2018;57:929–38.PubMedCrossRef Purpura M, Lowery RP, Wilson JM, Mannan H, Münch G, Razmovski-Naumovski V. Analysis of different innovative formulations of curcumin for improved relative oral bioavailability in human subjects. Eur J Nutr. 2018;57:929–38.PubMedCrossRef
24.
go back to reference Lan L, Braiteh FS, Kurzrock R. Liposome-encapsulated Curcumin in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104(6):1322–31. Lan L, Braiteh FS, Kurzrock R. Liposome-encapsulated Curcumin in vitro and in vivo effects on proliferation, apoptosis, signaling, and angiogenesis. Cancer. 2005;104(6):1322–31.
25.
go back to reference Hussain U, Zia K, Iqbal R, Saeed M, Ashraf N. Efficacy of a novel food supplement (Ferfer®) containing microencapsulated Iron in liposomal form in female Iron deficiency anemia. Cureus. 2019;11(5):e4603.PubMedPubMedCentral Hussain U, Zia K, Iqbal R, Saeed M, Ashraf N. Efficacy of a novel food supplement (Ferfer®) containing microencapsulated Iron in liposomal form in female Iron deficiency anemia. Cureus. 2019;11(5):e4603.PubMedPubMedCentral
26.
go back to reference Shade CW. Liposomes as advanced delivery Systems for Nutraceuticals. Integr Med (Encinitas). 2016;15(1):33–6. Shade CW. Liposomes as advanced delivery Systems for Nutraceuticals. Integr Med (Encinitas). 2016;15(1):33–6.
27.
go back to reference Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem. 2009;57:9141–6.PubMedCrossRef Takahashi M, Uechi S, Takara K, Asikin Y, Wada K. Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin. J Agric Food Chem. 2009;57:9141–6.PubMedCrossRef
28.
go back to reference Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011;74:664–9.PubMedCrossRef Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011;74:664–9.PubMedCrossRef
29.
go back to reference Nonose N, Pereira JA, Machado PRM, Rodrigues MR, Sato DT, Martinez CAR. Oral administration of curcumin (Curcuma longa) can attenuate the neutrophil inflammatory response in zymosan-induced arthritis in rats. Acta Cir Bras. 2014;29(11):727–34.PubMedCrossRef Nonose N, Pereira JA, Machado PRM, Rodrigues MR, Sato DT, Martinez CAR. Oral administration of curcumin (Curcuma longa) can attenuate the neutrophil inflammatory response in zymosan-induced arthritis in rats. Acta Cir Bras. 2014;29(11):727–34.PubMedCrossRef
30.
go back to reference Alghadir A, Miraj M, Ali S. Efficacy of Curcumin with Iontophoretic Application on Paw Edema and Hematological Responses in Collagen-Induced Arthritis Rat Models. Evidence-Based Complementary and Alternative Medicine. 2020; Article ID 4606520. Alghadir A, Miraj M, Ali S. Efficacy of Curcumin with Iontophoretic Application on Paw Edema and Hematological Responses in Collagen-Induced Arthritis Rat Models. Evidence-Based Complementary and Alternative Medicine. 2020; Article ID 4606520.
31.
go back to reference Wang Q, Ye C, Sun S, Li R, Shi X, Wang S, Zeng X, Kuang N, Liu Y, Shi Q, Liu R. Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects. Int Immunopharmacol. 2019;72:292–300.PubMedCrossRef Wang Q, Ye C, Sun S, Li R, Shi X, Wang S, Zeng X, Kuang N, Liu Y, Shi Q, Liu R. Curcumin attenuates collagen-induced rat arthritis via anti-inflammatory and apoptotic effects. Int Immunopharmacol. 2019;72:292–300.PubMedCrossRef
32.
go back to reference Jackson JK, Higo T, Hunter WL, Burt HM. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res Off J Eur Histamine Res Soc Al. 2006;55:168–75. Jackson JK, Higo T, Hunter WL, Burt HM. The antioxidants curcumin and quercetin inhibit inflammatory processes associated with arthritis. Inflamm Res Off J Eur Histamine Res Soc Al. 2006;55:168–75.
33.
go back to reference Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of Curcumin. Curr Pharm Des. 2013;19:2032–46.PubMed Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of Curcumin. Curr Pharm Des. 2013;19:2032–46.PubMed
35.
go back to reference Mhaske D, Sreedharan S, Mahadik K. Role of Piperine as an effective bioenhancer in drug absorption. Pharm Anal Acta. 2018;9:7. Mhaske D, Sreedharan S, Mahadik K. Role of Piperine as an effective bioenhancer in drug absorption. Pharm Anal Acta. 2018;9:7.
36.
37.
go back to reference Weissig V. Liposomes came first: the early history of Liposomology. Methods Mol Biol Clifton NJ. 2017;1522:1–15.CrossRef Weissig V. Liposomes came first: the early history of Liposomology. Methods Mol Biol Clifton NJ. 2017;1522:1–15.CrossRef
38.
go back to reference Šimoliūnas E, Rinkūnaitė I, Bukelskienė Ž, Bukelskienė V. Bioavailability of different vitamin D Oral supplements in laboratory animal model. Medicina (Kaunas). 2019;55(6):E265.CrossRef Šimoliūnas E, Rinkūnaitė I, Bukelskienė Ž, Bukelskienė V. Bioavailability of different vitamin D Oral supplements in laboratory animal model. Medicina (Kaunas). 2019;55(6):E265.CrossRef
39.
go back to reference Mbiantcha M, Almas J, Shabana SU, Nida D, Aisha F. Anti-arthritic property of crude extracts of Piptadeniastrum africanum (Mimosaceae) in complete Freund’s adjuvant-induced arthritis in rats. BMC Complement Altern Med. 2017;17(1):111.PubMedPubMedCentralCrossRef Mbiantcha M, Almas J, Shabana SU, Nida D, Aisha F. Anti-arthritic property of crude extracts of Piptadeniastrum africanum (Mimosaceae) in complete Freund’s adjuvant-induced arthritis in rats. BMC Complement Altern Med. 2017;17(1):111.PubMedPubMedCentralCrossRef
40.
go back to reference Cecchi I. Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N. neutrophils: novel key players in rheumatoid arthritis. Current and future therapeutic targets. Autoimmun. Rev. 2018;17:1138–49. Cecchi I. Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N. neutrophils: novel key players in rheumatoid arthritis. Current and future therapeutic targets. Autoimmun. Rev. 2018;17:1138–49.
41.
go back to reference Arora R, Kuhad A, Kaur IP, Chopra K. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur J Pain. 2015;19:940–52.PubMedCrossRef Arora R, Kuhad A, Kaur IP, Chopra K. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur J Pain. 2015;19:940–52.PubMedCrossRef
42.
go back to reference Kim H, Kim Y, Lee J. Liposomal formulations for enhanced lymphatic drug delivery. Asian J. Pharm. Sci., Special issue on Liposomes. 2013;8:96–103. Kim H, Kim Y, Lee J. Liposomal formulations for enhanced lymphatic drug delivery. Asian J. Pharm. Sci., Special issue on Liposomes. 2013;8:96–103.
43.
go back to reference Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev J Clin Ther. 2010;15:337–44. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G. Efficacy and safety of Meriva®, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev J Clin Ther. 2010;15:337–44.
Metadata
Title
Anti-inflammatory effect of different curcumin preparations on adjuvant-induced arthritis in rats
Authors
Ieva Rinkunaite
Egidijus Simoliunas
Milda Alksne
Dominyka Dapkute
Virginija Bukelskiene
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2021
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-021-03207-3

Other articles of this Issue 1/2021

BMC Complementary Medicine and Therapies 1/2021 Go to the issue